BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients.
Goelen
G
G
Department of Cancer Prevention, Vrije Universiteit Brussels, Belgium.
Rigo
A
A
Bonduelle
M
M
De Grève
J
J
D024682:BRCA2 Protein; D004992:Ethics, Medical; D005260:Female; D019398:Genes, BRCA1; D005819:Genetic Markers; D005820:Genetic Testing; D006801:Humans; D008297:Male; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics* / Q000517:prevention & control* / Q000523:psychology; D010342:Patient Acceptance of Health Care; D011237:Predictive Value of Tests; D014157:Transcription Factors / Q000235:genetics*
D024682:BRCA2 Protein; D005819:Genetic Markers; D009363:Neoplasm Proteins; D014157:Transcription Factors